Related Experiment Video
Updated: Jan 18, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
[A Study on Obstructive Colorectal Cancer Cases Undergoing Primary Tumor Resection Following Chemotherapy after
Akihiko Morita1, Shiori Okamoto, Sota Kimura
1Dept. of Surgery, IMS Tokyo Katsushika General Hospital.
Abstract:
We experienced 15 cases of obstructive colorectal cancer treated with chemotherapy after colonic stent placement. Fourteen cases were classified as cStage Ⅲ or Ⅳ, primarily involving distant metastases or extensive local invasion. Chemotherapy, mainly oxaliplatin-based and oral anticancer regimens, was administered for a median of 4 courses before primary tumor resection(median BTS duration:125 days). Although RECIST-defined partial response(PR)was observed in 3 cases, imaging revealed tumor shrinkage in 13 cases, facilitating easier surgical resection. No severe adverse events or stent-related complications were observed during chemotherapy. Compared with cases undergoing surgery without prior chemotherapy (median BTS duration:30 days), operative time, blood loss, and postoperative complication rates were similar, confirming the safety of surgery following stent placement and chemotherapy. Chemotherapy during stent placement and subsequent primary tumor resection was performed safely and may become a viable treatment option.

